[breadcrumb_custom]

Longboard Pharmaceuticals Inc Inc. (LBPH) Price Performance: The Role of Share Buybacks and Stock Splits

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 220.40%. However, over the last six months, the performance has been weaker by 197.69%. The price of LBPH decreased -17.79% over the last 30 days. And in the last five days, it has fallen by -8.65%.

The stock market performance of Longboard Pharmaceuticals Inc has been very steady. Over the last year, the company’s stock hit its highest at $28.15 on 01/23/24, while the lowest price during the same time frame was $3.60, recorded on 11/30/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of LBPH Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Longboard Pharmaceuticals Inc’s current trading price is -31.37% away from its 52-week high, while its distance from the 52-week low is 436.67%. The stock’s price range for this period has been between $3.60 and $28.15. The Healthcare sector company’s shares saw a trading volume of about 0.56 million for the day, which was lower than the average daily volume of 1.24 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Longboard Pharmaceuticals Inc (LBPH) has experienced a quarterly rise of 259.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 654.18M and boasts a workforce of 33 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.96, with a change in price of +13.09. Similarly, Longboard Pharmaceuticals Inc recorded 785,643 in trading volume during the last 100 days, posting a change of +210.11%.

LBPH’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for LBPH stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

LBPH Stock Stochastic Average

As of today, the raw stochastic average of Longboard Pharmaceuticals Inc over the last 50 days is at 64.03%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 4.23%. Further, the company’s Stochastic %K and %D values for the last 20 days were 13.94% and 12.24%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts